Bigul

Medico Intercontinental Ltd - 539938 - Shareholding for the Period Ended December 31, 2021

Medico Intercontinental Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here
12-01-2022
Bigul

Medico Intercontinental Ltd - 539938 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dear Sir / Ma'am, We are enclosing herewith the Confirmation Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st December, 2021. Kindly take the above on your record.
05-01-2022
Bigul

Medico Intercontinental Ltd - 539938 - Statement Of Investor Complaints For The Quarter Ended December 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Puneeta SharmaDesignation :- Company Secretary and Compliance Officer
05-01-2022
Bigul

Medico Intercontinental Ltd - 539938 - Declaration Regarding Regulation 23 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 In Respect Of Related Party Disclosures.

As per the provisions of 15(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR Regulations'), the compliances with corporate governance provisions as specified in Regulations 17 to 27 are applicable to the Company only if it's paid up Capital exceeds Rs. 10 Crores and if Net worth is above Rs. 25 Crores. As per audited financials of 31st March, 2021, the paid up share capital of the company is Rs. 3,24,90,000/- (Rupees Three Crores Twenty Four Lakhs Ninety Thousand only) which does not exceed Rs. 10 Crores limit and the Net Worth of the Company is Rs. 6,34,00,160/- (Rupees Six Crores Thirty Four Lakhs and One Hundred Sixty only) which does not cross Rs. 25 Crores. Hence, the compliance of provisions of Regulations 17 to 27 of SEBI (LODR) Regulations, 2015 is not applicable to the Company. In light of the above, the Company do not fall under the ambit of Regulation 23 (9) of SEBI (LODR) Regulations, 2015. Kindly take the same on record.
13-11-2021
Bigul

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Dear Sir / Ma'am, We hereby wish to inform you that the Unaudited financial results (Standalone & Consolidated) for the quarter and half year ended 30th September, 2021 were approved at the meeting of Board of Directors held on Friday, 12th November, 2021. In continuation to the same, the newspaper clipping duly published in English and Gujarati Newspaper is enclosed herewith. This is for your information and records.
13-11-2021
Bigul

Medico Intercontinental Ltd - 539938 - Results For The Quarter And Half Year Ended 30/09/2021

Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., November 12, 2021, inter alia, considered and approved unaudited Standalone and Consolidated Financial Results, Statement of Assets & Liabilities and Cash Flow Statement of the Company for the quarter and half year ended on September 30, 2021 along with Limited Review Report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed 'Standalone and Consolidated Unaudited Financial Results, Statement of Assets & Liabilities and Cash Flow Statement along with Limited Review Report' for the quarter and half year ended on September 30, 2021 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 11:30 A.M. and concluded at 01:40 P.M.
12-11-2021
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Outcome for Outcome Of Board Meeting And Compliances Of Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015.

Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., November 12, 2021, inter alia, considered and approved unaudited Standalone and Consolidated Financial Results, Statement of Assets & Liabilities and Cash Flow Statement of the Company for the quarter and half year ended on September 30, 2021 along with Limited Review Report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed 'Standalone and Consolidated Unaudited Financial Results, Statement of Assets & Liabilities and Cash Flow Statement along with Limited Review Report' for the quarter and half year ended on September 30, 2021 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 11:30 A.M. and concluded at 01:40 P.M.
12-11-2021
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Board Meeting In Compliance Of Regulation 29, 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021 ,inter alia, to consider and approve Dear Sir/Ma'am, With reference to the captioned subject, we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday, 12th November, 2021 at the registered office of the Company situated at 1-5th Floor, Aditraj Arcade, Nr Karma Shreshtha Tower, 100 Ft Rd, Satellite, Ahmedabad, Gujarat - 380015, to inter alia consider, approve and take on record the unaudited Financial Results (Standalone and Consolidated) along with Statement of Assets and Liabilities and Cash Flow Statement for quarter and half year ended 30th September, 2021 and any other business items as per agenda circulated. You are requested to kindly take the same on your record.
01-11-2021
Bigul

Medico Intercontinental Ltd - 539938 - Shareholding for the Period Ended September 30, 2021

Medico Intercontinental Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here
12-10-2021
Bigul

Medico Intercontinental Ltd - 539938 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Medico Intercontinental Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
04-10-2021
Next Page
Close

Let's Open Free Demat Account